
Manos MetzakopianPhD
Biography
The company reports a former CSO role at bit.bio, group leadership at the UK Dementia Research Institute Cambridge and work on genome-wide CRISPR screens in neurons.
The cofounders and scientific leadership bring company-reported experience in cell engineering, functional genomics, computational biology and life-sciences company building.

The company reports a former CSO role at bit.bio, group leadership at the UK Dementia Research Institute Cambridge and work on genome-wide CRISPR screens in neurons.

The company identifies him as founder of The Bioinformatics CRO and former VP Bioinformatics at bit.bio, with machine-learning and single-cell genomics experience.

The company reports previous communications leadership at Scorpion Therapeutics and business-development and scaling experience. This previous-employer history is not a CellCodex acquisition claim.

The company describes a life-sciences entrepreneurial background across academia, biotechnology and pharma.
The company identifies cofounding Prozymi Biolabs and experience in synthetic biology, DNA assembly and cellular engineering.
The company reports over 13 years in genetic engineering and functional genomics, including a decade at the Wellcome Sanger Institute.
Biographies and roles are company-attributed in the verified extraction.